| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |